Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.
Yi-Hao YenJin-Bor ChenBen-Chung ChengJung-Fu ChenKuo-Chin ChangPo-Lin TsengCheng-Kun WuMing-Chao TsaiMing-Tsung LinTsung-Hui HuPublished in: PloS one (2017)
The prevalence of NAFLD in the hemodialysis patients was 56%. The number of diagnoses of NAFLD made by using CAP combined with ultrasound was more than 2 times the number made with ultrasound alone in the hemodialysis patients. Therefore, we suggest the use of CAP combined with ultrasound to screen for NAFLD in hemodialysis patients.